DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Renal Impairment - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Impairment (71)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 71   Next >>

Possible Neoral side effects in 25 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13

Patient: 25 year old female

Reactions: Pseudomonas Infection, Nephropathy Toxic, Lung Transplant Rejection, Toxicity To Various Agents, Respiratory Distress, Renal Failure, COR Pulmonale Acute, Renal Impairment, Overdose, Lung Disorder, Pulmonary Oedema, Hypoxia, Acute Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Targocid
    Dosage: unk
    End date: 2012-01-23

Previgen
    Dosage: 100 mg/ml, unk
    End date: 2012-01-24

Neoral
    Dosage: 75 mg, bid
    Indication: Lung Transplant
    Start date: 2009-11-01
    End date: 2012-01-23

Other drugs received by patient: Boniva; Vitamin D; Neorecormon; Flecainide Acetate; Propyl-Thiouracil; Ceftazidime; Creon; Tenormin; Olimel; Venofer; Zithromax; Prednisone TAB; Ursolvan; Chlormadinone Acetate TAB; Lantus; Atarax; Ciprofloxacin Hydrochloride



Possible Neoral side effects in male

Reported by a consumer/non-health professional from Italy on 2012-08-08

Patient: male

Reactions: Nephrolithiasis, Renal Impairment

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-06

Patient: male, weighing 52.0 kg (114.4 pounds)

Reactions: Back Pain, Drug Resistance, Blood Triglycerides Increased, General Physical Health Deterioration, Neoplasm Progression, C-Reactive Protein Decreased, Kidney Transplant Rejection, Renal Failure Chronic, Post Transplant Lymphoproliferative Disorder, Renal Impairment

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Certican
    Dosage: 2.75 mg, unk
    Administration route: Oral
    Start date: 2007-07-28
    End date: 2007-10-07

Prograf
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2001-01-01
    End date: 2006-12-01

Prograf
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2008-08-01
    End date: 2008-08-22

Certican
    Dosage: 2.75 mg, unk
    Administration route: Oral
    Start date: 2008-09-07
    End date: 2008-09-27

Certican
    Dosage: 4 mg, unk
    Administration route: Oral
    Start date: 2009-07-19

Neoral
    Dosage: unk ukn, unk
    Indication: Renal Transplant
    Start date: 2001-01-01
    End date: 2006-01-01

Certican
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2007-07-24
    End date: 2007-07-27

Certican
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2008-08-25
    End date: 2008-09-06

Prograf
    Dosage: 4 mg, unk
    Administration route: Oral
    Start date: 2002-02-19
    End date: 2007-07-12

Prograf
    Dosage: 2.25 mg, unk
    Administration route: Oral
    Start date: 2008-08-23
    End date: 2008-08-25

Certican
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2009-06-06
    End date: 2009-07-18

Certican
    Dosage: 4.25 mg, daily
    Administration route: Oral
    Start date: 2009-08-22
    End date: 2009-09-03

Certican
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2007-07-13
    End date: 2007-07-23

Certican
    Dosage: 1.75 mg, unk
    Start date: 2008-08-01
    End date: 2008-08-24

Certican
    Dosage: 4.75 mg, unk
    Administration route: Oral
    Start date: 2009-11-13
    End date: 2010-03-02

Prednisolone
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2008-07-30

Certican
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2007-10-08

Certican
    Dosage: 3.25 mg, unk
    Administration route: Oral
    Start date: 2008-09-28
    End date: 2009-06-05

Prograf
    Dosage: 0.5 mg, unk
    Administration route: Oral
    Start date: 2007-07-13

Certican
    Dosage: 4.5 mg, daily
    Administration route: Oral
    Start date: 2009-09-04
    End date: 2009-11-12

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 1995-01-01
    End date: 2001-01-01

Prograf
    Dosage: 3.5 mg, unk
    Administration route: Oral
    Start date: 2008-07-29
    End date: 2008-07-30

Prograf
    Dosage: 1.5 mg, unk
    Administration route: Oral
    Start date: 2008-09-28
    End date: 2008-10-02

Certican
    Dosage: 1.25 mg, unk
    Administration route: Oral
    Start date: 2008-07-30
    End date: 2008-07-30

Prograf
    Dosage: 2 mg, unk
    Administration route: Oral
    Start date: 2008-08-26
    End date: 2008-09-27

Other drugs received by patient: Mycophenolate Mofetil; Chemotherapeutics NOS; Pravastatin Sodium; Trandolapril; Prednisolone; Mycophenolate Mofetil; Steroids NOS; Pravastatin Sodium; Azathioprine Sodium; Candesartan Cilexetil; Mycophenolate Mofetil; Tacrolimus



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-06

Patient: male, weighing 52.0 kg (114.4 pounds)

Reactions: Back Pain, Drug Resistance, Blood Triglycerides Increased, General Physical Health Deterioration, Neoplasm Progression, C-Reactive Protein Decreased, Kidney Transplant Rejection, Renal Failure Chronic, Post Transplant Lymphoproliferative Disorder, Renal Impairment

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Certican
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2007-07-13
    End date: 2007-07-23

Certican
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2007-07-24
    End date: 2007-07-27

Prograf
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2008-08-01
    End date: 2008-08-22

Certican
    Dosage: 1.75 mg, unk
    Start date: 2008-08-01
    End date: 2008-08-24

Certican
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2008-08-25
    End date: 2008-09-06

Neoral
    Dosage: unk ukn, unk
    Indication: Renal Transplant
    Start date: 2001-01-01
    End date: 2006-01-01

Certican
    Dosage: 2.75 mg, unk
    Administration route: Oral
    Start date: 2007-07-28
    End date: 2007-10-07

Certican
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2007-10-08

Certican
    Dosage: 3.25 mg, unk
    Administration route: Oral
    Start date: 2008-09-28
    End date: 2009-06-05

Certican
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2009-06-06
    End date: 2009-07-18

Certican
    Dosage: 4.75 mg, unk
    Administration route: Oral
    Start date: 2009-11-13
    End date: 2010-03-02

Prograf
    Dosage: 2.25 mg, unk
    Administration route: Oral
    Start date: 2008-08-23
    End date: 2008-08-25

Prograf
    Dosage: 2 mg, unk
    Administration route: Oral
    Start date: 2008-08-26
    End date: 2008-09-27

Certican
    Dosage: 4.25 mg, daily
    Administration route: Oral
    Start date: 2009-08-22
    End date: 2009-09-03

Certican
    Dosage: 4.5 mg, daily
    Administration route: Oral
    Start date: 2009-09-04
    End date: 2009-11-12

Prednisolone
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2008-07-30

Prograf
    Dosage: 4 mg, unk
    Administration route: Oral
    Start date: 2002-02-19
    End date: 2007-07-12

Prograf
    Dosage: 3.5 mg, unk
    Administration route: Oral
    Start date: 2008-07-29
    End date: 2008-07-30

Certican
    Dosage: 2.75 mg, unk
    Administration route: Oral
    Start date: 2008-09-07
    End date: 2008-09-27

Prograf
    Dosage: 1.5 mg, unk
    Administration route: Oral
    Start date: 2008-09-28
    End date: 2008-10-02

Certican
    Dosage: 1.25 mg, unk
    Administration route: Oral
    Start date: 2008-07-30
    End date: 2008-07-30

Certican
    Dosage: 4 mg, unk
    Administration route: Oral
    Start date: 2009-07-19

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 1995-01-01
    End date: 2001-01-01

Prograf
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2001-01-01
    End date: 2006-12-01

Prograf
    Dosage: 0.5 mg, unk
    Administration route: Oral
    Start date: 2007-07-13

Other drugs received by patient: Prednisolone; Tacrolimus; Mycophenolate Mofetil; Mycophenolate Mofetil; Azathioprine Sodium; Chemotherapeutics NOS; Trandolapril; Steroids NOS; Pravastatin Sodium; Mycophenolate Mofetil; Pravastatin Sodium; Candesartan Cilexetil



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Argentina on 2012-07-26

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Renal Impairment, Bacteraemia, Ischaemic Stroke, Urinary Tract Infection, Dehydration, Septic Shock, Cardiac Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Myfortic
    Dosage: 720 mg, bid
    Administration route: Oral
    Start date: 2011-12-16
    End date: 2012-01-24

Neoral
    Dosage: unk
    Indication: Renal Transplant
    Start date: 2012-01-26
    End date: 2012-01-28

Prograf
    Dosage: 10 mg, unk
    Administration route: Oral

Prograf
    Dosage: 4 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-12-16
    End date: 2012-01-25



Possible Neoral side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-16

Patient: 69 year old male

Reactions: Generalised Oedema, Weight Increased, Renal Impairment, Neoplasm Malignant, Gastrointestinal Disorder, Bone Marrow Failure, Pleural Effusion, Fluid Retention, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09

Patient: female, weighing 39.0 kg (85.8 pounds)

Reactions: Renal Impairment, Pneumonia, Cardiac Failure, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Exjade
    Dosage: 1000 mg, daily
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2009-05-27
    End date: 2009-07-07

Neoral
    Indication: Myelodysplastic Syndrome

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2009-05-27
    End date: 2009-11-24

Exjade
    Dosage: 725 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-30
    End date: 2009-11-24

Other drugs received by patient: Blood Transfusion, Auxiliary Products; Primobolan-Depot INJ; Prednisolone Sodium Succinate INJ; RED Blood Cells, Concentrated; RED Blood Cells, Concentrated



Possible Neoral side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-06

Patient: 51 year old female

Reactions: RED Blood Cell Abnormality, Blood Lactate Dehydrogenase Increased, Platelet Count Increased, Anxiety, Renal Impairment, Platelet Count Decreased, Renal Tubular Necrosis, Haemolytic Uraemic Syndrome, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-06-08
    End date: 2010-06-09

Sandimmune
    Dosage: 200 mg, daily
    Start date: 2010-06-11
    End date: 2010-06-11

Sandimmune
    Dosage: 175 mg, daily
    Indication: Renal Transplant
    End date: 2010-06-11

Other drugs received by patient: Cefaclor; Adalat; Atarax; Pancreaze; Gamofa; Prednisolone Sodium Succinate INJ; Prograf; Tacrolimus; Amlodipine; Sucralfate; Alosenn; Gamofa; Prednisolone Sodium Succinate INJ; Prednisolone Sodium Succinate INJ; Prograf; Prograf; Allegra; Doxazosin Mesylate; Cefazolin Sodium; Nicardipine HCL; Simulect; Simulect; Doxazosin Mesylate; Aspirin; Sodium Picosulfate; Rabeprazole Sodium; Prednisolone Sodium Succinate INJ; Prednisolone Sodium Succinate INJ; Lasix; Spanidin; Venilon; Cellcept; Nafamostat; Medrol; Carvedilol; Alosenn; Buscopan



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-06

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Hydronephrosis, Maternal Exposure During Pregnancy, Urinary Tract Infection, Pyrexia, Premature Labour, Device Occlusion, Renal Impairment, Ureteral Spasm, C-Reactive Protein Increased, Blood Creatinine Increased, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Antihypertensives; Bredinin; Allopurinol; Diovan; Medrol; Imuran; Prednisolone Sodium Succinate INJ



Possible Neoral side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 65 year old male

Reactions: Portal Hypertension, Polyarteritis Nodosa, Hepatic Function Abnormal, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Hepatic Cirrhosis, Arterial Stenosis, Necrosis of Artery

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone; Oxygen



Possible Neoral side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 65 year old male

Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Ascites, Pulmonary Fibrosis, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone; Oxygen



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-06-18

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Urine Output Decreased, Pancytopenia, Condition Aggravated, Pyrexia, Ascites, Renal Failure, Renal Impairment, Hepatic Cirrhosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 420 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2012-04-13
    End date: 2012-04-19

Neoral
    Dosage: 250 mg, qd
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-04-20

Neoral
    Dosage: 125 mg, unk
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-10

Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-13

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2012-04-21
    End date: 2012-05-09

Other drugs received by patient: Adrenal Hormone Preparations; Omeprazole; Primobolan-Depot INJ; Diflucan; Losartan Potassium; Sodium Chloride; Corticosteroid NOS; Pursennid; Gran; Pyrinazin; Solu-Medrol; Thymoglobulin; Lactec; Lactec; Omeprazole; Valtrex



Possible Neoral side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 65 year old male

Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone; Oxygen



Possible Neoral side effects in male

Reported by a pharmacist from Japan on 2012-06-14

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Urine Output Decreased, Condition Aggravated, Pancytopenia, Pyrexia, Ascites, Renal Failure, Renal Impairment, Hepatic Cirrhosis

Drug(s) suspected as cause:
Neoral
    Dosage: 250 mg, qd
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-04-20

Neoral
    Dosage: 125 mg, unk
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-10

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2012-04-21
    End date: 2012-05-09

Neoral
    Dosage: 420 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2012-04-13
    End date: 2012-04-19

Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-13

Other drugs received by patient: Omeprazole; Lactec; Adrenal Hormone Preparations; Primobolan-Depot INJ; Sodium Chloride; Thymoglobulin; Diflucan; Valtrex; Losartan Potassium; Lactec; Gran; Corticosteroid NOS; Omeprazole; Pyrinazin; Pursennid; Solu-Medrol



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-06-07

Patient: female, weighing 13.0 kg (28.6 pounds)

Reactions: Nasopharyngitis, Nausea, Pyrexia, Respiratory Syncytial Virus Infection, Renal Impairment, Diarrhoea, Interstitial Lung Disease, Heart Transplant Rejection, Rash Erythematous, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prograf
    Dosage: 4.5 mg, unk
    Administration route: Oral
    Start date: 2006-01-23
    End date: 2006-02-16

Certican
    Dosage: 1 mg, unk
    Administration route: Oral
    Start date: 2006-01-30
    End date: 2006-02-03

Certican
    Dosage: 0.75 mg, unk
    Administration route: Oral
    Start date: 2006-02-03
    End date: 2006-04-24

Certican
    Dosage: 0.5 mg, unk
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2006-01-23
    End date: 2006-01-30

Neoral
    Indication: Heart Transplant

Cellcept
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2009-02-01

Certican
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2008-01-23
    End date: 2009-01-22

Azathioprine
    Administration route: Oral
    Indication: Heart Transplant

Tacrolimus
    Indication: Heart Transplant

Prograf
    Dosage: 4.8 mg, unk
    Administration route: Oral
    Indication: Heart Transplant
    End date: 2006-01-23

Prograf
    Dosage: 4.0 mg, unk
    Administration route: Oral
    Start date: 2006-03-20
    End date: 2006-04-24

Certican
    Dosage: unk
    Administration route: Oral
    End date: 2009-02-05

Certican
    Dosage: unk

Prograf
    Dosage: 3.0 mg, unk
    Administration route: Oral
    Start date: 2006-02-16
    End date: 2006-03-20

Other drugs received by patient: Everolimus; Tenormin; Sirolimus; Famotidine



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-05-22

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Renal Impairment, Hepatic Function Abnormal, Blood Creatinine Increased, Serum Ferritin Increased, Gastritis

Drug(s) suspected as cause:
Neoral
    Dosage: 200 mg, daily
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2005-08-02

Exjade
    Dosage: 500 mg, daily
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2009-09-08
    End date: 2009-11-09

Exjade
    Dosage: 500 mg, daily
    Administration route: Oral
    Start date: 2009-11-10

Neoral
    Dosage: 200 mg, daily
    Administration route: Oral

Other drugs received by patient: Primobolan-Depot INJ; Norvasc; Norvasc; Allopurinol; Allopurinol; RED Blood Cells, Concentrated



Possible Neoral side effects in 77 year old male

Reported by a physician from Japan on 2012-05-21

Patient: 77 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Renal Impairment, Hyperuricaemia, Disease Progression

Drug(s) suspected as cause:
Exjade
    Dosage: 500 mg, qw3
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2011-01-12
    End date: 2011-09-21

Neoral
    Dosage: 300 mg, daily
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2011-01-12
    End date: 2011-02-16

Neoral
    Dosage: 250 mg, daily
    Administration route: Oral
    Start date: 2011-02-17
    End date: 2011-04-20

Exjade
    Dosage: 500 mg, qw5
    Administration route: Oral
    Start date: 2011-09-21
    End date: 2012-01-12

Neoral
    Dosage: 200 mg,daily
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2012-01-12

Other drugs received by patient: Magmitt Kenei; RED Blood Cells, Concentrated; Allopurinol; RED Blood Cells, Concentrated; Gasmotin; Lasix



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-18

Patient: female, weighing 47.0 kg (103.4 pounds)

Reactions: Renal Impairment, Nausea, Cerebral Haemorrhage, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2009-05-13
    End date: 2009-06-09

Exjade
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2008-08-07
    End date: 2008-08-20

Exjade
    Dosage: 1000 mg, unk
    Administration route: Oral
    Start date: 2008-10-02
    End date: 2010-05-03

Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    Start date: 2008-11-06
    End date: 2008-12-17

Neoral
    Dosage: 125 mg, unk
    Administration route: Oral
    Start date: 2009-06-10
    End date: 2009-08-26

Exjade
    Dosage: 500 mg, unk
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2008-08-21
    End date: 2008-10-01

Neoral
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2003-06-01
    End date: 2008-11-05

Neoral
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2008-12-18
    End date: 2009-05-12

Other drugs received by patient: Adona; Levofloxacin; Blood Cells, Packed Human; Desferal; Lipitor; Mucosta; Neutrogin; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Transamine CAP; Glakay; Maxipime; Blood Cells, Packed Human; Amlodipine Besylate; Ampicillin; Norvasc; Lasoprazole; Blood Cells, Packed Human; Sulbactam Sodium; Onealfa; Tranexamic Acid; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human



Possible Neoral side effects in male

Reported by a consumer/non-health professional from Denmark on 2012-04-30

Patient: male

Reactions: Complications of Transplanted Kidney, Renal Disorder, Gout, Kidney Fibrosis, Osteopenia, Nephrosclerosis, Blood Calcium Decreased, Vascular Calcification, Osteonecrosis, Renal Impairment, Arthralgia, Blood Uric Acid Increased, Spinal Osteoarthritis, Renal Graft Loss

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Rapamune; Mycophenolate Mofetil (Cellcept); Myfortic; Prednisolone



Possible Neoral side effects in female

Reported by a physician from United States on 2012-04-27

Patient: female

Reactions: Abdominal Discomfort, Renal Impairment, Diarrhoea, Dehydration, Flatulence, Urinary Bladder Rupture, Open Wound, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in 25 year old male

Reported by a consumer/non-health professional from Japan on 2012-04-23

Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Itraconazole
    Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-06-06
    End date: 2009-07-16

Foscavir
    Dosage: form:inj1 df= 10 unit nos
    Start date: 2009-07-10
    End date: 2009-07-16

Bactrim
    Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
    Administration route: Oral
    Indication: Antibiotic Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-16

Farom
    Administration route: Oral
    Start date: 2009-04-28
    End date: 2009-05-01

Neoral
    Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-08

Sprycel
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-04-16
    End date: 2009-07-08

Maxipime
    Start date: 2009-04-24
    End date: 2009-04-27

Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone



Possible Neoral side effects in male

Reported by a physician from France on 2012-04-20

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Bronchial Obstruction, Klebsiella Infection, Thrombocytopenia, Post Procedural Haemorrhage, Escherichia Sepsis, Renal Vessel Disorder, Complications of Transplanted Kidney, Wound Dehiscence, Anaemia, Malnutrition, Anastomotic Haemorrhage, Wound Complication, Renal Impairment, Diarrhoea, Cytomegalovirus Infection, Renal Tubular Necrosis, Pneumonia Escherichia, Asthenia, Leukopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-02-10

Mycophenolate Mofetil (Cellcept)
    Dosage: 1 g, per day
    Administration route: Oral
    Start date: 2011-03-01
    End date: 2011-03-08

Bactrim
    Dosage: 400 mg, per day
    Administration route: Oral
    Start date: 2011-01-24
    End date: 2011-02-01

RAD 666 / RAD 001a
    Dosage: 3 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-02-02
    End date: 2011-02-09

Neoral
    Dosage: 100 mg, qd
    Administration route: Oral
    Start date: 2011-02-27
    End date: 2011-03-16

Neoral
    Dosage: unk

Mycophenolate Mofetil (Cellcept)
    Dosage: 2 g, per day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-15
    End date: 2011-02-09

Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-17
    End date: 2011-02-01

Prednisone TAB
    Dosage: 40 mg, per day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-16

Zantac
    Dosage: 150 mg, per day
    Administration route: Oral
    Start date: 2011-02-02

Valganciclovir
    Dosage: 250 mg, 9qd
    Administration route: Oral
    Start date: 2011-01-29
    End date: 2011-02-01

Nexium
    Dosage: 40 mg, per day
    Administration route: Oral
    Start date: 2011-01-16
    End date: 2011-02-01

Other drugs received by patient: Solu-Medrol; Lasix; Adancor; Esomeprazole Magnesium; Calcidia; Pantoprazole; Aspirin; Sodium Bicarbonate; Amlodipine Besylate; Econazole Nitrate; Amoxicillin; Imodium; Simulect; Eprex; Insulatard NPH Human; Potassium Chloride; Nitroderm; Mirtazapine; Aluminum Hydroxide and Magnesium Trisilicate; Alfuzosin HCL; Cotrim



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-04-19

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Pyrexia, Rash, Kidney Transplant Rejection, Urine Abnormality, Hypokinesia, Renal Impairment, Cytomegalovirus Infection, Pneumonia Staphylococcal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Simulect
    Dosage: 20 mg, once/single
    Indication: Renal Transplant
    Start date: 2010-01-20
    End date: 2010-01-20

Rituxan
    Dosage: 200 mg, unk
    Start date: 2010-05-25

Mycophenolate Mofetil (Cellcept)
    Dosage: 1800 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-01-06
    End date: 2010-01-19

Mycophenolate Mofetil (Cellcept)
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2010-01-24

Mycophenolate Mofetil (Cellcept)
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2010-01-21

Neoral
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-01-17
    End date: 2010-01-19

Neoral
    Dosage: 200 mg
    Administration route: Oral
    Start date: 2010-03-02
    End date: 2010-10-03

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2010-10-04

Prednisolone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-01-24
    End date: 2010-01-25

Prednisolone
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2010-01-29
    End date: 2010-01-30

Simulect
    Dosage: 20 mg, once/single
    Start date: 2010-01-24
    End date: 2010-01-24

Neoral
    Dosage: 300 mg, qd
    Start date: 2010-01-23
    End date: 2010-02-06

Neoral
    Dosage: 150 mg, unk
    Start date: 2011-01-24
    End date: 2011-10-12

Neoral
    Dosage: 250 mg, qd
    Administration route: Oral
    Start date: 2010-02-07
    End date: 2010-03-01

Neoral
    Dosage: 100 mg, unk
    Start date: 2011-10-13

Sandimmune
    Dosage: 100 mg, unk
    Indication: Renal Transplant
    Start date: 2010-01-20
    End date: 2010-01-22

Prednisolone
    Dosage: 30 mg, unk
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2010-01-28

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2010-01-31

Rituxan
    Dosage: 200 mg, unk
    Indication: Kidney Transplant Rejection
    Start date: 2010-01-13
    End date: 2010-01-13

Other drugs received by patient: Spanidin; Solu-Medrol; Adalat CC; Adalat; Solu-Medrol



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-04-18

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Pneumonia, Renal Impairment, Neoplasm Malignant, Platelet Count Increased, Neoplasm Progression, Pyrexia, Upper Respiratory Tract Inflammation, White Blood Cell Count Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2011-03-10
    End date: 2011-06-20

Neoral
    Dosage: 20 mg, daily
    Administration route: Oral
    Start date: 2010-10-15
    End date: 2010-10-21

Ambisome
    Dosage: 140 mg, daily
    Start date: 2011-07-05
    End date: 2011-07-20

Exjade
    Dosage: 125 mg daily
    Administration route: Oral
    Start date: 2011-03-01
    End date: 2011-03-08

Neoral
    Dosage: 200 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2010-08-03
    End date: 2010-09-27

Exjade
    Dosage: 1500 mg,daily
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2010-08-03
    End date: 2010-08-09

Exjade
    Dosage: 500 mg, daily
    Administration route: Oral
    Start date: 2010-09-07
    End date: 2010-10-15

Ambisome
    Dosage: 140 mg, daily
    Start date: 2011-06-10
    End date: 2011-06-27

Ambisome
    Dosage: 150 mg, daily
    Indication: Pneumonia
    Start date: 2011-03-01
    End date: 2011-03-18

Exjade
    Dosage: 625 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2010-08-10
    End date: 2010-08-30

Exjade
    Dosage: 500 mg, daily
    Administration route: Oral
    Start date: 2010-08-31
    End date: 2010-09-06

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Start date: 2010-10-09
    End date: 2010-10-14

Other drugs received by patient: Cotrim; Cotrim; Zolpidem; Rohypnol; Zithromax; Lastet S; RED Cells Concentrated; RED Cells Concentrated; Pursennid; Diflucan; Allopurinol; RED Cells Concentrated; Pursennid; Ciprofloxacin; Hydrea; Allopurinol; Lastet S; Sucralfate; Sucralfate; RED Cells Concentrated; Lansoprazole; Loxonin; Hydrea; RED Cells Concentrated; RED Cells Concentrated; Lansoprazole; Zolpidem; Loxonin; Primobolan-Depot INJ; Lasix; Mucosolvan; RED Cells Concentrated; RED Cells Concentrated; RED Cells Concentrated; Aspirin; Ciprofloxacin; Rohypnol; Lastet S; RED Cells Concentrated; Pursennid; Magnesium Oxide; Cefepime Hydrochloride; RED Cells Concentrated; RED Cells Concentrated; Lansoprazole; Diflucan; Primobolan-Depot INJ; Milmag; Aspirin



Possible Neoral side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 50 year old male

Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased

Drug(s) suspected as cause:
Sandimmune
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Erythrodermic Psoriasis
    Start date: 1994-01-01

Neoral
    Indication: Erythrodermic Psoriasis

Remicade
    Dosage: unk ukn, unk
    Indication: Erythrodermic Psoriasis
    Start date: 2008-08-01
    End date: 2011-05-01

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Psoriasis
    Start date: 1994-01-01
    End date: 2008-08-01



Possible Neoral side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10

Patient: 50 year old male

Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased

Drug(s) suspected as cause:
Sandimmune
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Erythrodermic Psoriasis
    Start date: 1994-01-01

Neoral
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Psoriasis
    Start date: 1994-01-01
    End date: 2008-08-01

Neoral
    Indication: Erythrodermic Psoriasis

Remicade
    Dosage: unk ukn, unk
    Indication: Erythrodermic Psoriasis
    Start date: 2008-08-01
    End date: 2011-05-01



Possible Neoral side effects in 13 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-06

Patient: 13 year old male

Reactions: Blood Pressure Increased, Vomiting, Nausea, Coma, Blood Albumin Decreased, Headache, Convulsion, Renal Impairment, Visual Impairment, Posterior Reversible Encephalopathy Syndrome

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone



Possible Neoral side effects in male

Reported by a pharmacist from Ireland on 2012-04-02

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Renal Impairment, Nephropathy Toxic, Dehydration, Oedema, Rash, Toxicity To Various Agents, Blood Creatinine Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 150 mg, bid
    Indication: Rheumatoid Arthritis

Prograf

Neoral
    Indication: Transplant

Tacrolimus
    Dosage: 1 df, variable dose target trough 10-12
    Start date: 2011-07-14

Tacrolimus
    Dosage: 1 df, variable dose target trough 10-12
    Start date: 2010-10-14

Tobi
    Dosage: 300 mg, bid
    Indication: Pseudomonas Infection
    Start date: 2011-09-06
    End date: 2011-12-01

Other drugs received by patient: Myfortic; Sterimar; Magnesium; Prednisolone; Alfacalcidol; Furosemide; Micera; Lansoprazole; Alendronate Sodium; Nystatin; Azithromycin; Symbicort; Vitamin D; Septin; Folic Acid; Fungizone; Bicarbonate; Chlorhexidine Gluconate; Atorvastatin; Calcium Carbonate; Immunosuppressants



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-03-23

Patient: male

Reactions: Dyspnoea, Hepatic Function Abnormal, Liver Disorder, Renal Impairment, Renal Failure, Cardiac Failure, Respiratory Failure, Heart Rate Increased, Oedema Peripheral, Pleural Effusion, Immunosuppressant Drug Level Increased, Renal Tubular Necrosis, Hypertension, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Allegra; Candesartan Cilexetil; Tigason



Possible Neoral side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-20

Patient: 67 year old female

Reactions: Atelectasis, Lymphadenopathy, Corneal Perforation, Conjunctivitis, Glossitis, Forced Expiratory Volume Decreased, Ulcerative Keratitis, Obliterative Bronchiolitis, Erythema, Alternaria Infection, Skin Ulcer, Lymphocytic Lymphoma, Bronchial Wall Thickening, Bronchospasm, Blister, Stomatitis, Dyspnoea, Pneumonia, Subcutaneous Abscess, Pain of Skin, Rash, Respiratory Distress, Renal Impairment, Respiratory Failure, Fungal Skin Infection, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014